(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-30 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 579510
Date | Daily Closing Price | Open | High | Low | Volume |
30 Mon Sep 2024 | 5.28 | 5.16 | 5.29 | 5.03 | 0.197 times |
27 Fri Sep 2024 | 5.15 | 5.10 | 5.27 | 5.02 | 0.261 times |
26 Thu Sep 2024 | 5.09 | 5.20 | 5.23 | 5.01 | 0.537 times |
25 Wed Sep 2024 | 5.20 | 5.16 | 5.41 | 5.07 | 0.612 times |
24 Tue Sep 2024 | 5.18 | 5.41 | 5.41 | 4.98 | 0.842 times |
23 Mon Sep 2024 | 5.44 | 5.95 | 6.05 | 5.31 | 1.113 times |
20 Fri Sep 2024 | 5.91 | 5.67 | 6.07 | 5.61 | 1.567 times |
19 Thu Sep 2024 | 5.61 | 5.66 | 5.82 | 5.49 | 0.476 times |
18 Wed Sep 2024 | 5.48 | 5.26 | 5.72 | 5.25 | 0.791 times |
17 Tue Sep 2024 | 5.50 | 5.96 | 6.15 | 5.47 | 0.886 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 5.6 as stoploss in an intra day sell trade for a target of 4.96. However, stock will show a bullish move above 5.6.
Share price targets for Corvus Pharmaceuticals (CRVS)
Target Type | Value |
Downside Target | 1.43 |
Downside Target | 1.75 |
Downside Target | 2.28 |
Downside Target | 2.35 |
Downside Target | 2.47 |
Downside Target | 3.00 |
Downside Target | 3.90 |
Downside Target | 4.00 |
Downside Target | 4.60 |
Downside Target | 4.75 |
Downside Target | 4.98 |
Downside Target | 5.22 |
Upside Target | 5.29 |
Upside Target | 6.05 |
Upside Target | 6.15 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
Target Type | Value |
Downside Intraday Target | 5.11 |
Downside Intraday Target | 4.94 |
Upside Intraday Target | 5.37 |
Upside Intraday Target | 5.46 |
Downside Intraday Target | 5.2 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Mon Sep 2024 | 5.28 | 5.16 | 5.29 | 5.03 | 0.059 times |
27 Fri Sep 2024 | 5.15 | 5.95 | 6.05 | 4.98 | 0.507 times |
20 Fri Sep 2024 | 5.91 | 5.25 | 6.15 | 5.25 | 1.302 times |
13 Fri Sep 2024 | 5.10 | 4.03 | 5.22 | 4.00 | 2.392 times |
06 Fri Sep 2024 | 4.03 | 4.45 | 4.60 | 3.90 | 1.553 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Mon Sep 2024 | 5.28 | 4.45 | 6.15 | 3.90 | 0.922 times |
30 Fri Aug 2024 | 4.48 | 2.74 | 4.75 | 2.47 | 3.106 times |
31 Wed Jul 2024 | 2.57 | 1.81 | 3.00 | 1.75 | 1.015 times |
28 Fri Jun 2024 | 1.82 | 2.15 | 2.28 | 1.78 | 0.456 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.47 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.47 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.